Literature DB >> 7497467

Overexpressions of c-fos/jun mRNA and their oncoproteins (Fos/Jun) in the mouse uterus treated with three natural estrogens.

S Morishita1, K Niwa, S Ichigo, M Hori, T Murase, J Fujimoto, T Tamaya.   

Abstract

To further understand hormonal carcinogenesis of natural estrogens (estrone, 17 beta-estradiol (E2) and estriol), we determined the expressions of c-fos/jun mRNA, and their oncoproteins (Fos/Jun) with intracellular localization in the uterus of ovarectomized mice treated with these estrogens. Mid-term chronic, as well as short-term assays were examined. Of three estrogens examined, mid-term chronic E2-treatment significantly increased the expression of c-fos/jun mRNA, and their oncoproteins (Fos/Jun). These were most prominently expressed in glandular cells of E2-treated mouse endometrium. Therefore, mid-term chronic E2-treatment might partially induce glandular cell transformation of uterine endometrium via overexpression of Fos/Jun.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7497467     DOI: 10.1016/0304-3835(95)03979-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.

Authors:  Sema Bircan; Arzu Ensari; Sibel Ozturk; Nural Erdogan; Ilkkan Dundar; Firat Ortac
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

Review 2.  Crosstalk between IGF1R and estrogen receptor signaling in breast cancer.

Authors:  Dedra H Fagan; Douglas Yee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-12       Impact factor: 2.673

Review 3.  Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.

Authors:  R I Nicholson; J M Gee
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

4.  Identification of therapeutic targets for breast cancer using biological informatics methods.

Authors:  Xuejian Liu; Yongzhen Ma; Wenchuan Yang; Xia Wu; Lihua Jiang; Xiangli Chen
Journal:  Mol Med Rep       Date:  2015-03-27       Impact factor: 2.952

5.  Preventive effects of Glycyrrhizae radix extract on estrogen-related endometrial carcinogenesis in mice.

Authors:  K Niwa; M Hashimoto; S Morishita; Y Yokoyama; H Mori; T Tamaya
Journal:  Jpn J Cancer Res       Date:  1999-07

6.  Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice.

Authors:  Z Lian; K Niwa; K Tagami; M Hashimoto; J Gao; Y Yokoyama; H Mori; T Tamaya
Journal:  Jpn J Cancer Res       Date:  2001-07

7.  Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy.

Authors:  Zhuan Zhou; Joe X Qiao; Amit Shetty; George Wu; Yi Huang; Nancy E Davidson; Yong Wan
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.207

8.  Effects of tamoxifen on endometrial carcinogenesis in mice.

Authors:  K Niwa; S Morishita; M Hashimoto; T Itoh; J Fujimoto; H Mori; T Tamaya
Journal:  Jpn J Cancer Res       Date:  1998-05

9.  Inhibitory effects of toremifene on N-methyl-N-nitrosourea and estradiol-17beta-induced endometrial carcinogenesis in mice.

Authors:  Kenji Niwa; Midori Hashimoto; Zenglin Lian; Jingchun Gao; Keiko Tagami; Yasuhiro Yokoyama; Hideki Mori; Teruhiko Tamaya
Journal:  Jpn J Cancer Res       Date:  2002-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.